On Friday, Shares of Horizon Pharma PLC (NASDAQ:HZNP), inclined 3.68% to $21.11, during its last trading session.
Horizon Pharma plc, declared that its associate Horizon Pharma Switzerland GmbH has reached a settlement and license agreement with Actavis Laboratories FL, Inc. to resolve pending patent litigation involving RAYOS® (prednisone) Delayed-Release Tablets.
Under the settlement and license agreement, Horizon has granted Actavis the right to market a version of delayed-release prednisone tablets in the United States under the Actavis Abbreviated New Drug Application (ANDA), startning December 23, 2022 or earlier under certain circumstances.
The agreement comprises a stipulation by the parties requesting dismissal with prejudice of the lawsuit filed by Horizon in the U.S. District Court for the District of New Jersey and regarding the ANDA filed by Actavis with the U.S. Food and Drug Administration for a version of delayed-release prednisone tablets.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.
At the end of Friday’s trade, Shares of Performance Food Group Co (NYSE:PFGC), gained 10.31% to $21.18.
Performance Food Group Company, declared it will ring the New York Stock Exchange Opening Bell recently, Friday, October 2, 2015 in celebration of its initial public offering.
“We are honored to take part in the New York Stock Exchange Opening Bell ceremony as a newly listed company,” said George Holm, PFGC’s President and Chief Executive Officer. “The bell ringing ceremony is an exciting way to celebrate this important milestone for our company and to acknowledge the commitment and support of our valued associates, customers, vendors and investors.”
Performance Food Group Company distributes food and food-related products in the United States. The company operates through three divisions: Foodservice, Vistar, and PFG Customized.
Finally, Kimco Realty Corp (NYSE:KIM), ended its last trade with 1.70% gain, and closed at $24.89.
RioCan Real Estate Investment Trust and Kimco Realty Corp., declared that after fifteen successful years as partners, RioCan and Kimco have agreed to unwind their Canadian joint venture. The portfolio of 35 jointly owned properties (“RioKim Portfolio”) will be divided into three groups:
- the first group is a collection of 22 properties selected by RioCan that will be attained in two stages: 19 properties during the third quarter of 2015 and three properties in the first quarter of 2016;
- the second group comprises of ten institutional-quality retail assets which the partners have agreed to market for sale, one of which is presently under a conditional contract to be sold; and
- the third group of assets comprises three transitional properties that were formerly occupied by Target, which will be dealt with at a future date.
In March 2015, RioCan attained Kimco’s 50% interest in Grand Park and RioCan Leaside Centre in Toronto, Ontario, in addition to Brentwood Village in Calgary, Alberta. The joint venture partners also accomplished the sale of Centres Jacques Cartier on July 31, 2015 at a sale price of $18 million ($9 million at RioCan’s interest). The property was sold free and clear of financing.
Kimco Realty Corporation is an independent real estate investment trust. The firm invests in the real estate markets across North America. It is primarily engaged in acquisitions, development, and administration of neighborhood and community shopping centers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
